OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

RetinalGenix Technologies Inc.

CIK 0001836295Ticker RTGNSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events33

captured official filings

Registration & offering21

captured official filings

Ownership0

captured official filings

Governance0

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1 filed 2022-01-21 with S-1/A filed 2022-01-26.

Earlier SEC filingLatest SEC filing
433latest comparable sentences
5new-text candidates
6prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares57 → 59+2

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED JANUARY 26, 2022 1,259,368 Shares of Common Stock This prospectus relates to the sale by the selling stockholders named in this prospectus (the “Selling Stockholders”) of RetinalGenix Technologies Inc. (the “Company”) of 1,259,368 shares of common stock,
  • The Selling Stockholders will sell their Resale Shares at $1.00 per share until our shares are quoted on the OTCQB, OTCQX or listed on a national securities exchange, such as the NYSE American or The Nasdaq Capital Market, and thereafter at prevailing market prices or in privately negotiated transactions.
  • Offering price: The selling stockholders (the “Selling Stockholders”) will sell their Resale Shares at $1.00 per share until our shares are quoted on the OTCQB, OTCQX or listed on a national securities exchange, such as the NYSE American or The Nasdaq Capital Market, and thereafter at prevailing market prices or in p
Present in earlier filing, not found in latest
  • PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED JANUARY 21, 2022 1,259,368 Shares of Common Stock This prospectus relates to the sale by the selling stockholders named in this prospectus (the “Selling Stockholders”) of RetinalGenix Technologies Inc. (the “Company”) of 1,259,368 shares of common stock,
  • Our common stock is quoted on the OTC Pink tier of the OTC Markets Group, Inc. under the symbol “RTGN.” The Selling Stockholders may sell their Resale Shares at prevailing market prices or in privately negotiated transactions.
  • Offering price: The selling stockholders (the “Selling Stockholders”) may sell their Resale Shares at prevailing market prices or in privately negotiated transactions.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 8-K
    Reporting & material eventsOpen SEC filing →
  2. 10-Q
    Reporting & material eventsOpen SEC filing →
  3. 10-K
    Reporting & material eventsOpen SEC filing →
  4. 8-K
    Reporting & material eventsOpen SEC filing →
  5. 10-Q
    Reporting & material eventsOpen SEC filing →
  6. 10-Q/A
    Reporting & material eventsOpen SEC filing →
  7. 10-Q
    Reporting & material eventsOpen SEC filing →
  8. EFFECT
    Registration & offeringOpen SEC filing →
  9. EFFECT
    Registration & offeringOpen SEC filing →
  10. 10-Q
    Reporting & material eventsOpen SEC filing →
  11. 10-K
    Reporting & material eventsOpen SEC filing →
  12. 8-K
    Reporting & material eventsOpen SEC filing →
  13. 10-Q
    Reporting & material eventsOpen SEC filing →
  14. 10-Q
    Reporting & material eventsOpen SEC filing →
  15. 10-Q
    Reporting & material eventsOpen SEC filing →
  16. EFFECT
    Registration & offeringOpen SEC filing →
  17. EFFECT
    Registration & offeringOpen SEC filing →
  18. 8-K
    Reporting & material eventsOpen SEC filing →
  19. 10-K
    Reporting & material eventsOpen SEC filing →
  20. EFFECT
    Registration & offeringOpen SEC filing →
  21. EFFECT
    Registration & offeringOpen SEC filing →
  22. 8-K
    Reporting & material eventsOpen SEC filing →
  23. 8-K
    Reporting & material eventsOpen SEC filing →
  24. 10-Q
    Reporting & material eventsOpen SEC filing →
  25. 10-Q
    Reporting & material eventsOpen SEC filing →
  26. 10-K/A
    Reporting & material eventsOpen SEC filing →
  27. 10-Q/A
    Reporting & material eventsOpen SEC filing →
  28. 10-Q
    Reporting & material eventsOpen SEC filing →
  29. 10-K
    Reporting & material eventsOpen SEC filing →
  30. 424B3
    Registration & offeringOpen SEC filing →
  31. 424B3
    Registration & offeringOpen SEC filing →
  32. 10-Q
    Reporting & material eventsOpen SEC filing →
  33. 424B3
    Registration & offeringOpen SEC filing →
  34. 424B3
    Registration & offeringOpen SEC filing →
  35. 10-Q
    Reporting & material eventsOpen SEC filing →
  36. 8-K
    Reporting & material eventsOpen SEC filing →
  37. 8-K
    Reporting & material eventsOpen SEC filing →
  38. EFFECT
    Registration & offeringOpen SEC filing →
  39. EFFECT
    Registration & offeringOpen SEC filing →
  40. 10-Q/A
    Reporting & material eventsOpen SEC filing →
  41. 10-Q
    Reporting & material eventsOpen SEC filing →
  42. 10-K
    Reporting & material eventsOpen SEC filing →
  43. 8-K
    Reporting & material eventsOpen SEC filing →
  44. 424B3
    Registration & offeringOpen SEC filing →
  45. EFFECT
    Registration & offeringOpen SEC filing →
  46. S-1/A
    Registration & offeringOpen SEC filing →
  47. S-1
    Registration & offeringOpen SEC filing →
  48. 424B3
    Registration & offeringOpen SEC filing →
  49. 8-K
    Reporting & material eventsOpen SEC filing →
  50. 10-Q
    Reporting & material eventsOpen SEC filing →
  51. 424B3
    Registration & offeringOpen SEC filing →
  52. EFFECT
    Registration & offeringOpen SEC filing →
  53. S-1/A
    Registration & offeringOpen SEC filing →
  54. S-1
    Registration & offeringOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.